Serban Ghiorghiu

Serban Ghiorghiu

Company: AstraZeneca & European Commission’s Mission for Cancer, Board Member

Job title: Head of Clinical, Late Development Oncology R&D


The Osimertinib Story – Innovating & Learning from Every Chapter to Beat T790M Resistance & Advance into Early EGFRm Disease 9:10 am

Chapter 1 – Delivering one of the fastest-ever development programmes: Tackling T790M driven resistance through novel chemistry; creating innovative study designs focused on patient selection, selecting the right dose, driving seamless worldwide trials and registration strategies; and acting fast on what we learned from the data to rapidly expand into first-line and adjuvant settings. Chapter…Read more

day: Day One

© Copyright 2022 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.